Melanie H. Muhlstock of Parker Waichman LLP Named to Leadership Role in National Elmiron® Litigation January 26, 2021 (New York) - Melanie H. Muhlstock, Managing Partner of the Mass Torts Department for the national law firm Parker Waichman LLP, has been named to the Executive Committee of the Plaintiffs’ Steering Committee in … [Read more...] about Press Release – Melanie H. Muhlstock of Parker Waichman LLP Named to Leadership Role in National Elmiron® Litigation
While Elmiron lawsuits are piling up, a few important questions to address include who manufactures the medication and what it takes to sue them. Video source: How much will it cost me to use the maker of Elmiron? Do You Have Elmiron-Related Questions? Fill in the form below and Jerry will do his best to personally reply to … [Read more...] about Elmiron Makers: Who Makes Elmiron and How Much Will it Cost to Sue Them?
In light of emerging Elmiron lawsuits, we are discussing and answering popular questions around the medication. This time, we are discussing possible Elmiron lawsuit settlement amounts: Has there been an Elmiron lawsuit settlement yet, and what would the lawsuit compensation be? Has There Been an Elmiron Lawsuit Settlement Yet? At … [Read more...] about Has There Been Elmiron Lawsuit Settlement Yet?
The short answer is that you can file an individual Elmiron lawsuit (provided you meet the criteria), but there’s no such thing as an Elmiron class action. To go more in-depth, that’s a common misconception and a real misunderstanding about the law in the United States. When you’re claiming a personal injury as a result of a … [Read more...] about Can I Become Part of an Elmiron Class Action Lawsuit?
Parker Waichman LLP Files an Elmiron® Lawsuit On Behalf of the Firm's Client in California Who Suffers Vision Loss, Pigmentary Maculopathy, & Irreversible Retinal Damage Due to Elmiron®. PORT WASHINGTON, NY - July 8, 2020 - According to an online press release published on PRNewswire.com, Parker Waichman LLP, a national … [Read more...] about Elmiron® Pigmentary Maculopathy Lawsuits
Parker Waichman Representing California Woman With Irreversible Retinal Damage, Including Maculopathy, and Severely Impaired Vision Resulting From Use of Elmiron Parker Waichman LLP, a national law firm that has long fought to protect the rights of victims injured by allegedly defective drugs and defective medical devices, filed … [Read more...] about Press Release – Parker Waichman LLP Files Lawsuit Against Manufacturers of Elmiron on Behalf of California Woman
JANSSEN PHARMACEUTICAL COMPANIES, A SUBSIDIARY OF JOHNSON & JOHNSON, NOTES IN ITS LABEL THAT ELMIRON USERS SHOULD BE INFORMED THAT CHANGES IN VISION SHOULD BE NOTED AND EVALUATED NEW YORK - In the background of mounting litigation, drug manufacturer, Janssen Pharmaceutical Companies, a subsidiary of drug giant, Johnson & … [Read more...] about Press Release – Parker Waichman comments on dramatic change in Elmiron® drug label
Elmiron, or pentosan polysulfate sodium, which is a medication designed to combat bladder conditions and has been used for several decades, could damage the patient’s retina, according to Science Daily. Researchers now say that the medication is potentially toxic to the retina, which is the light-sensing tissue located in the rear … [Read more...] about Elmiron Side Effects: Bladder Medication Vision Problems, Elmiron Eye Damage & Retinal Toxicity